Wallingford, PA, United States of America

Ronald L Magolda

USPTO Granted Patents = 14 

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 107(Granted Patents)


Location History:

  • Aston, PA (US) (1987 - 1991)
  • Wallington, PA (US) (2001)
  • Wallingford, PA (US) (1992 - 2010)

Company Filing History:


Years Active: 1987-2010

Loading Chart...
14 patents (USPTO):

Title: The Innovative Contributions of Ronald L. Magolda

Introduction

Ronald L. Magolda is a prominent inventor based in Wallingford, PA, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, he has made remarkable advancements in the development of therapeutic compounds and diagnostic methods.

Latest Patents

Among his latest patents is the invention titled "Tetracyclic indoles as potassium channel modulators." This invention focuses on compounds that serve as potassium channel modulators and includes pharmaceutical compositions derived from these compounds. The patent also outlines methods of treatment utilizing these compounds and the synthetic processes for their production. Another notable patent is "Antibodies to aggrecan-degrading metalloprotease and diagnostic methods using same." This invention pertains to a family of aggrecan degrading metallo proteases (ADMPs) that can cleave the aggrecan core protein. It encompasses the nucleic acids encoding these enzymes, processes for producing recombinant ADMPs, and their applications in various assays and therapies for diseases related to cartilage degradation.

Career Highlights

Throughout his career, Ronald has worked with esteemed organizations such as the DuPont Merck Pharmaceutical Company and E.I. du Pont de Nemours and Company. His work in these companies has significantly influenced the pharmaceutical industry, particularly in drug development and innovative therapeutic solutions.

Collaborations

Ronald has collaborated with notable colleagues, including James M. Trzaskos and Irina Cipora Jacobson. These partnerships have fostered a collaborative environment that has led to groundbreaking research and development in their respective fields.

Conclusion

In summary, Ronald L. Magolda's contributions to the field of pharmaceuticals through his patents and collaborations have made a lasting impact. His innovative work continues to influence the development of new therapies and diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…